Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxepin rinse for acute oral mucositis pain
NCT02229539Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxepin in oral mucositis (OM), sponsored by Cancer and Leukemia Group B. Started Nov 2014; status: completed.
02
Drugs
doxepin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02229539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229539.